Top Health Tools
Top Health Tools

Top Reports
Top Reports
 
Top Articles
Top Articles

Top Reviews
Top Reviews
   
GlaxoSmithKline To Start Shipping
Untested H1N1 Vaccines Next Week

GlaxoSmithKline who have not completed any clinical trials to assess the safety of H1N1 vaccines, expects to start shipping out its vaccine next week to governments across Europe so that mass vaccinations against the virus can begin.

Governments and drugmakers have been scrambling for vaccines to combat the new H1N1 flu strain before a fear hyped second wave of infection hits the northern hemisphere in the winter.

The world's second biggest pharmaceutical company said on Wednesday it will begin shipments of its Pandemrix vaccine from next week, after getting official clearance from the European Commission on Tuesday.

According to infectious disease experts, due to delayed and potentially serious side effects, the timelines for effective safety testing on adjuvanted vaccines should span years from initial clinical trials. Yet the vaccines about to be shipped to Europeans offer no data or conclusive evidence to health regulators on vaccine safety.

A full list of ingredients, warnings and side effects for all H1N1 vaccine inserts is available here.

European officials also gave a green light to Swiss drugmaker Novartis for its H1N1 shot Focetria which also contains untested and dangerous adjuvants such as MF59.


Reference Sources 89
September 30, 2009

Share/Bookmark
...............................................................................................................

This site is owned and operated by PreventDisease.com 1999-2014. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
aaa
Interact
volunteerDonateWrite For Us
Stay Connected With Our Newsletter